AA
SPTX

ALPS Advisors’s Seaport Therapeutics SPTX Stock Holding History

ALPS Advisors’s Portfolio SPTX Stock Details SPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
+54,328
New +$956K 0.01% 656

Other funds holding SPTX

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

ALPS Advisors's SPTX Position: Q2 2026 in Review

ALPS Advisors opened a new position in Seaport Therapeutics (SPTX) in Q2 2026: 54,328 shares worth $1.18M. The stake represents 0.01% of the portfolio and ranks #656 among its holdings.

5 funds tracked by Wall St. Rank hold SPTX as of Q2 2026.

  • ALPS Advisors held 54,328 shares of Seaport Therapeutics worth $1.18M as of Q2 2026.
  • Seaport Therapeutics was a new ALPS Advisors position in Q2 2026.
  • Seaport Therapeutics made up 0.01% of ALPS Advisors's portfolio in Q2 2026, its #656 holding.
  • 5 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.